{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:58:44Z","timestamp":1790521124145,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.neurol.2007.08.012","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T14:13:58Z","timestamp":1204899238000},"page":"634-645","source":"Crossref","is-referenced-by-count":4,"title":["Narcolepsie avec cataplexie"],"prefix":"10.1016","volume":"164","author":[{"given":"Y.","family":"Dauvilliers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2007.08.012_bib1","series-title":"The international Classification of Sleep Disorders \u2013 Revised","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.neurol.2007.08.012_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0140-6736(91)92966-6","article-title":"Mazindol in long-term treatment of narcolepsy","volume":"337","author":"Alvarez","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2007.08.012_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson's disease and sleepiness: an integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib4","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/brain\/awh620","article-title":"Kleine-Levin syndrome: a systematic review of 186 cases in the literature","volume":"128","author":"Arnulf","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2007.08.012_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/28.6.667","article-title":"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study","volume":"28","author":"Auger","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(05)70196-4","article-title":"Hypocretins (orexins) and sleep-wake disorders","volume":"4","author":"Baumann","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/smrv.2001.0168","article-title":"Idiopathic hypersomnia","volume":"5","author":"Billiard","year":"2001","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neurol.2007.08.012_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-1331.2006.01473.x","article-title":"EFNS guidelines on management of narcolepsy","volume":"13","author":"Billiard","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/sleep\/28.4.427","article-title":"Analysis of hypocretin (orexin) antibodies in patients with narcolepsy","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2007.08.012_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/sleep\/9.4.519","article-title":"Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness","volume":"9","author":"Carskadon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2007.08.012_bib15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2869.2001.00234.x","article-title":"Health-related quality of life in narcolepsy","volume":"10","author":"Daniels","year":"2001","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2007.08.012_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.mp.4000911","article-title":"MAO-A and COMT polymorphisms and gene effects in narcolepsy","volume":"6","author":"Dauvilliers","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neurol.2007.08.012_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500088","article-title":"Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil","volume":"2","author":"Dauvilliers","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.neurol.2007.08.012_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/sleep\/26.6.663","article-title":"Month of birth as a risk factor for narcolepsy","volume":"26","author":"Dauvilliers","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib21","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S1388-2457(03)00203-7","article-title":"Clinical aspects and pathophysiology of narcolepsy","volume":"114","author":"Dauvilliers","year":"2003","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2007.08.012_bib22","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2007.08.012_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.20208","article-title":"A narcolepsy susceptibility locus maps to a 5Mb region of chromosome 21q","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000101725.34089.1E","article-title":"Effect of age on MSLT results in patients with narcolepsy-cataplexy","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins shortly after narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib26","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1212\/WNL.62.11.2137","article-title":"A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/07853890500489700","article-title":"Molecular genetics and treatment of narcolepsy","volume":"38","author":"Dauvilliers","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11910-996-0039-2","article-title":"Differential diagnosis in hypersomnia","volume":"6","author":"Dauvilliers","year":"2006","journal-title":"Curr Opin Neurol Neurosci"},{"key":"10.1016\/j.neurol.2007.08.012_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2007.08.012_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2869.2007.00601.x","article-title":"Periodic leg movements during sleep and wakefulness in narcolepsy","volume":"16","author":"Dauvilliers","year":"2007","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2007.08.012_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2007.08.012_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1378\/chest.108.3.619","article-title":"Vigilance and automobile accidents in patients with sleep apnea or narcolepsy","volume":"108","author":"Findley","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.neurol.2007.08.012_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2007.08.012_bib34","first-page":"626","article-title":"De la narcolepsie","volume":"53","author":"G\u00e9lineau","year":"1880","journal-title":"Gaz Hop (Paris)"},{"key":"10.1016\/j.neurol.2007.08.012_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-2-9","article-title":"ApoE polymorphisms in narcolepsy","volume":"2","author":"Gencik","year":"2001","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.neurol.2007.08.012_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2007.08.012_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-0039.1999.540204.x","article-title":"Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy","volume":"54","author":"Hohjoh","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.neurol.2007.08.012_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410350612","article-title":"The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort","volume":"35","author":"Hublin","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.1984.tb02144.x","article-title":"HLA antigens in Japanese patients with narcolepsy","volume":"24","author":"Juji","year":"1984","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.neurol.2007.08.012_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.sleep.2003.10.006","article-title":"A putative link between childhood narcolepsy and obesity","volume":"5","author":"Kotagal","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/sleep\/16.3.216","article-title":"Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study","volume":"16","author":"Lammers","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2007.08.012_bib44","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2007.08.012_bib45","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib46","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2007.08.012_bib47","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnostic of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib49","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awl079","article-title":"Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults","volume":"129","author":"Mignot","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2007.08.012_bib50","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2005.04.035","article-title":"Behavioral correlates of activity in identified hypocretin\/orexin neurons","volume":"46","author":"Mileykovskiy","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2007.08.012_bib51","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/geno.2000.6143","article-title":"Linkage of human narcolepsy with HLA association to chromosome 4p13-q21","volume":"65","author":"Nakayama","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.neurol.2007.08.012_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2004.11.007","article-title":"The association between narcolepsy and REM behavior disorder (RBD)","volume":"6","author":"Nightingale","year":"2005","journal-title":"Sleep Med."},{"key":"10.1016\/j.neurol.2007.08.012_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neurol.2007.08.012_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00227-4","article-title":"Prevalence of hallucinations and their pathological associations in the general population","volume":"97","author":"Ohayon","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neurol.2007.08.012_bib56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1212\/WNL.58.12.1826","article-title":"Prevalence of narcolepsy symptomatology and diagnosis in the European general population","volume":"58","author":"Ohayon","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2869.2004.00411.x","article-title":"Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia","volume":"13","author":"Overeem","year":"2004","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2007.08.012_bib58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","article-title":"Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy","volume":"174","author":"Overeem","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2007.08.012_bib59","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(79)92495-4","article-title":"Clomipramine and and clonazepam in narcolepsy","volume":"2","author":"Parkes","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2007.08.012_bib60","doi-asserted-by":"crossref","unstructured":"Pelin Z, Guilleminault C, Risch N, Grumet FC, Mignot E. (1998), HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens, 51: 96\u2013100.","DOI":"10.1111\/j.1399-0039.1998.tb02952.x"},{"key":"10.1016\/j.neurol.2007.08.012_bib61","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2007.08.012_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brain","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib63","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/sleep\/27.8.1471","article-title":"The month-of-birth pattern in narcolepsy is moderated by cataplexy severity and may be independent of HLA-DQB1*0602","volume":"27","author":"Picchioni","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/nbdi.2001.0389","article-title":"Hypocretin levels in sporadic and familial cases of canine narcolepsy","volume":"8","author":"Ripley","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2007.08.012_bib65","first-page":"291","article-title":"Depression in narcolepsy and hypersommia","volume":"116","author":"Roth","year":"1975","journal-title":"Schweiz Arch Neurol Neurochir Psychiatry"},{"key":"10.1016\/j.neurol.2007.08.012_bib66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2007.08.012_bib67","first-page":"11","article-title":"Modafinil: a drug in search of a mechanism","volume":"27","author":"Saper","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib68","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.0308458100","article-title":"Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy","volume":"101","author":"Siebold","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2007.08.012_bib69","first-page":"217","article-title":"Venlafaxine in the treatment of the narcoleptic syndrome","volume":"5","author":"Smith","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2007.08.012_bib70","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2007.08.012_bib71","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2007.08.012_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","author":"US Modafinil in Narcolepsy Multicenter Study Group","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2007.08.012_bib73","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","author":"US Modafinil in Narcolepsy Multicenter Study Group","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2007.08.012_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","article-title":"Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy","volume":"5","author":"US Xyrem Multicenter Study group","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib75","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","author":"US Xyrem Multicenter Study group","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2007.08.012_bib76","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00006842-200003000-00013","article-title":"Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications","volume":"62","author":"Vgontzas","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib77","first-page":"631","article-title":"Eigent\u00fcmliche mit Einschlafen Verbundene Anf\u00e4lle","volume":"7","author":"Westphal","year":"1877","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1016\/j.neurol.2007.08.012_bib78","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-004-0569-5","article-title":"Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA","volume":"82","author":"Wieczorek","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.neurol.2007.08.012_bib79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2007.08.012_bib80","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","article-title":"The occurrence of sleep-disordered breathing among middle-aged adults","volume":"328","author":"Young","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:27:56Z","timestamp":1557336476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378708000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":80,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0035378708000465"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2007.08.012","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}